HMIN [Homeinns Hotel] 6-K: Home Inns Reports Third Quarter 2012 Financial Results

[Home Inns Reports Third Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Revenuesreased 62% Year over Year to RMB 1.60 billion Motel 168 Hotels Occupancy Rate Improved to 83% Shanghai, November13, 2012 STYLE="font-family:Times New Roman" SIZE="2">Home Inns acquired Motel 168 and hasnsolidated Motel 168s operating and financial results since October1, 2011.nsolidated numbers are presented in]

By | 2016-02-05T19:32:09+00:00 November 14th, 2012|Categories: Chinese Stocks, HMIN, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]

By | 2016-03-01T04:25:03+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]

By | 2016-03-01T04:25:47+00:00 November 14th, 2012|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

CLNT [Cleantech Solutions International,] 8-K: (Original Filing)

[Companyntact: Ms. Wanfen Xu Crockerulson Chief Financial Officer CCG Investor Relations Cleantech Solutions International, Tel: +1 646 213 1915 Email: xu_wf@cleantechsolutionsinternational.com Email: Crocker.coulson@ccgir.com, Web: www.cleantechsolutionsinternational.com www.ccgirasia.com Web: Cleantech Solutions International Reports Third Quarter 2012 Results Wuxi, Jiangsu Province, China November 13, 2012 ,ainst a weak macro-economic background, we are very pleased to have achieved 48.5%] [Companyntact: Ms. Wanfen Xu, Chief Financial Officer E-mail: xu_wf@cleantechsolutionsinternational.com Cleantech Solutions International, www.cleantechsolutionsinternational.com Web: Investor Relationsntact: Crockerulson CCG Investor Relations Tel: +1 646 213 1915 crocker.coulson@ccgir.com Email: www.ccgirasia.com Web: Cleantech Solutions International Announcesnferencell to Discuss Third Quarter 2012 Financial Results Wuxi, Jiangsu Province, China November 9, 2012 Cleantech Solutions International,]

By | 2016-02-02T23:14:40+00:00 November 14th, 2012|Categories: Chinese Stocks, CLNT, SEC Original|Tags: , , , , , |0 Comments
Read More

CLNT [Cleantech Solutions International,] 8-K: Companyntact: Ms. Wanfen Xu Crockerulson Chief Financial Officer

[Companyntact: Ms. Wanfen Xu Crockerulson Chief Financial Officer CCG Investor Relations Cleantech Solutions International, Tel: +1 646 213 1915 Email: xu_wf@cleantechsolutionsinternational.com Email: Crocker.coulson@ccgir.com, Web: www.cleantechsolutionsinternational.com www.ccgirasia.com Web: Cleantech Solutions International Reports Third Quarter 2012 Results Wuxi, Jiangsu Province, China November 13, 2012 ,ainst a weak macro-economic background, we are very pleased to have achieved 48.5%] [Companyntact: Ms. Wanfen Xu, Chief Financial Officer E-mail: xu_wf@cleantechsolutionsinternational.com Cleantech Solutions International, www.cleantechsolutionsinternational.com Web: Investor Relationsntact: Crockerulson CCG Investor Relations Tel: +1 646 213 1915 crocker.coulson@ccgir.com Email: www.ccgirasia.com Web: Cleantech Solutions International Announcesnferencell to Discuss Third Quarter 2012 Financial Results Wuxi, Jiangsu Province, China November 9, 2012 Cleantech Solutions International,]

By | 2016-02-02T23:15:10+00:00 November 14th, 2012|Categories: Chinese Stocks, CLNT, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of September 30, 2012 (Unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months and Nine Months Ended September 30, 2012 and 2011 (Unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Weibing Lu, Chief Executive Officer v327445_ex32-1.htm 4 EX-32.1] [(2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Bing Mei, Chief Financial Officer v327445_ex32-2.htm 5 EX-32.2]

By | 2016-02-05T03:02:29+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

KNDI [Kandi Technologies] 10-Q: FORM 10-Q For the quarterly period ended September

[FORM 10-Q For the quarterly period ended September 30, 2012 or For the transition period from _____________ to _____________. Kandi Technologies, Corp. Delaware 90-0363723 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) Jinhua City Industrial Zone Jinhua, Zhejiang Province People’s Republic of China Post Code 321016 ___________ (86 - 579) 82239856 Yes [X] No [_] Yes] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Hu Xiaoming, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zhu Xiaoying, certify that: 1. I have reviewed this report on Form 10-Q of Kandi Technologies, Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. § 1350, § 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.]

By | 2016-03-18T14:15:14+00:00 November 14th, 2012|Categories: Chinese Stocks, KNDI, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended September 30, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer, Chief Accounting Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Director]

By | 2016-03-27T18:59:55+00:00 November 14th, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More
Skip to toolbar